← Open Payments lookup

OLUYEMISI ADEDOTUN: Open Payments

NPI 1629393632 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,734 in 150 payments from 15 companies in 2025. Trend: 2023 $3,346 · 2024 $2,498 · 2025 $2,734

Food & beverage: $2,727Education: $7
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$585
ABBVIE INC.21$411
Otsuka America Pharmaceutical, Inc.20$370
E.R. Squibb & Sons, L.L.C.16$315
Neurocrine BioSciences, Inc.16$215
Vanda Pharmaceuticals Inc.7$178
Lundbeck LLC11$163
Teva Pharmaceuticals USA, Inc.5$110
Sage Therapeutics, LLC6$105
Alkermes, Inc.5$101

Products named: CAPLYTA, REXULTI, VRAYLAR, COBENFY, INGREZZA, FANAPT, AUSTEDO XR, ZURZUVAE.

Industry payments across NV — which companies pay providers there.